Specifically, all groups except the young female group revealed the upregulation of pparγ and srebp1c, markers involved in de novo lipogenesis, along with the downregulation of the cAMP-responsive element-binding protein (creb313), which plays a protective role in the development of steatosis [135]. The gene discussed is SREBF1; the disease is steatosis.